Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases
- PMID: 33808574
- PMCID: PMC8003583
- DOI: 10.3390/ijms22063134
Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases
Abstract
COVID-19 is without any doubt the worst pandemic we have faced since the H1N1 virus outbreak. Even if vaccination against SARS-CoV-2 infection is becoming increasingly available, a more feasible approach for COVID-19 prevention and therapy is still needed. Evidence of a pathological link between metabolic diseases and severe forms of COVID-19 has stimulated critical reflection and new considerations. In particular, an abnormal immune response observed in certain patients with SARS-CoV-2 infection suggested possible common predisposing risk factors with autoimmune diseases such as Type 1 Diabetes (T1D). Correct supplementation with dietary factors may be key to preventing and counteracting both the underlying metabolic impairment and the complications of COVID-19. A set of agents may inhibit the cytokine storm and hypercoagulability that characterize severe COVID-19 infection: vitamin D3, omega-3 polyunsaturated fatty acids, polyphenols like pterostilbene, polydatin and honokiol, which can activate anti-inflammatory and antioxidant sirtuins pathways, quercetin, vitamin C, zinc, melatonin, lactoferrin and glutathione. These agents could be highly beneficial for subjects who have altered immune responses. In this review, we discuss the antiviral and metabolic effects of these dietary factors and propose their combination for potential applications in the prevention and treatment of COVID-19. Rigorous studies will be fundamental for validating preventive and therapeutic protocols that could be of assistance to mitigate disease progression following SARS-CoV-2 infection.
Keywords: COVID-19; metabolic diseases; natural supplements.
Conflict of interest statement
C.R. is scientific advisor of Fondazione Barilla Center for Food and Nutrition, Zone Labs and SIRT500 Sagl.
Figures


Similar articles
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
-
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?Int J Mol Sci. 2020 Jul 21;21(14):5171. doi: 10.3390/ijms21145171. Int J Mol Sci. 2020. PMID: 32708322 Free PMC article. Review.
-
Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.Exp Gerontol. 2020 Dec;142:111147. doi: 10.1016/j.exger.2020.111147. Epub 2020 Nov 7. Exp Gerontol. 2020. PMID: 33171276 Free PMC article. Review.
-
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1971-1975. doi: 10.23812/20-1-E. J Biol Regul Homeost Agents. 2020. PMID: 33016027
-
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.Rheumatol Int. 2021 Jan;41(1):7-18. doi: 10.1007/s00296-020-04636-y. Epub 2020 Jun 25. Rheumatol Int. 2021. PMID: 32588191 Free PMC article. Review.
Cited by
-
Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro.Biomedicines. 2021 Nov 19;9(11):1721. doi: 10.3390/biomedicines9111721. Biomedicines. 2021. PMID: 34829949 Free PMC article.
-
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial.Nutrients. 2023 Mar 4;15(5):1285. doi: 10.3390/nu15051285. Nutrients. 2023. PMID: 36904283 Free PMC article. Clinical Trial.
-
Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention.Int J Mol Sci. 2021 Nov 17;22(22):12385. doi: 10.3390/ijms222212385. Int J Mol Sci. 2021. PMID: 34830267 Free PMC article. Review.
-
Vitamin D3 and its necessity for health.Ann Med Surg (Lond). 2022 May 26;78:103872. doi: 10.1016/j.amsu.2022.103872. eCollection 2022 Jun. Ann Med Surg (Lond). 2022. PMID: 35669409 Free PMC article. No abstract available.
-
The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure?J Pharm Pharmacol Res. 2022 Aug 2;6(3):100-114. doi: 10.26502/fjppr.055. J Pharm Pharmacol Res. 2022. PMID: 37168835 Free PMC article.
References
-
- Jutzeler C.R., Bourguignon L., Weis C.V., Tong B., Wong C., Rieck B., Pargger H., Tschudin-Sutter S., Egli A., Borgwardt K., et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020;37:101825. doi: 10.1016/j.tmaid.2020.101825. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous